Literature DB >> 15251988

Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation.

Nghia T V Le1, Des R Richardson.   

Abstract

Iron (Fe) is critical for proliferation, but its precise role in cell cycle progression remains unclear. In this study, we examined the mechanisms involved by assessing the effects of Fe chelators on the expression of molecules that play key roles in this process. In initial studies, gene arrays were used to assess gene expression after incubating cells with 2 Fe chelators, namely, desferrioxamine (DFO) and 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone (311), or the DNA-damaging agent, actinomycin D. From the genes assessed, only the N-myc downstream-regulated gene 1 (Ndrg1) was specifically up-regulated by Fe chelation. Although the function of Ndrg1 is unclear, previous studies showed it markedly slows tumor growth and acts as a potent metastasis suppressor. Incubation of cells with chelators markedly increased Ndrg1 mRNA and protein expression, but this was not found with their Fe complexes or when the Fe-binding site had been inactivated. Increased Ndrg1 expression following Fe chelation was related to the permeability and antiproliferative activity of chelators and could be reversed by Fe repletion. Moreover, Ndrg1 up-regulation after chelation occurred at the transcriptional level and was mediated by hypoxia inducible factor-1alpha (HIF-1alpha)-dependent and -independent mechanisms. Our investigation suggests Ndrg1 is a novel link between Fe metabolism and the control of proliferation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15251988     DOI: 10.1182/blood-2004-05-1866

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  73 in total

Review 1.  Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Authors:  Heather A Leitch
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

Review 2.  Collateral sensitivity as a strategy against cancer multidrug resistance.

Authors:  Kristen M Pluchino; Matthew D Hall; Andrew S Goldsborough; Richard Callaghan; Michael M Gottesman
Journal:  Drug Resist Updat       Date:  2012-04-06       Impact factor: 18.500

Review 3.  Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.

Authors:  Megumi Iiizumi; Wen Liu; Sudha K Pai; Eiji Furuta; Kounosuke Watabe
Journal:  Biochim Biophys Acta       Date:  2008-07-22

Review 4.  Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling.

Authors:  Sharleen V Menezes; Sumit Sahni; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

5.  Bacterial siderophores that evade or overwhelm lipocalin 2 induce hypoxia inducible factor 1α and proinflammatory cytokine secretion in cultured respiratory epithelial cells.

Authors:  Victoria I Holden; Steven Lenio; Rork Kuick; Sadeesh K Ramakrishnan; Yatrik M Shah; Michael A Bachman
Journal:  Infect Immun       Date:  2014-06-30       Impact factor: 3.441

6.  "Function-first" lead discovery: mode of action profiling of natural product libraries using image-based screening.

Authors:  Christopher J Schulze; Walter M Bray; Marcos H Woerhmann; Joshua Stuart; R Scott Lokey; Roger G Linington
Journal:  Chem Biol       Date:  2013-02-21

7.  The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6.

Authors:  Sharleen V Menezes; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2019-01-24       Impact factor: 5.157

8.  Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia.

Authors:  Celine Callens; Séverine Coulon; Jerome Naudin; Isabelle Radford-Weiss; Nicolas Boissel; Emmanuel Raffoux; Pamella Huey Mei Wang; Saurabh Agarwal; Houda Tamouza; Etienne Paubelle; Vahid Asnafi; Jean-Antoine Ribeil; Philippe Dessen; Danielle Canioni; Olivia Chandesris; Marie Therese Rubio; Carole Beaumont; Marc Benhamou; Hervé Dombret; Elizabeth Macintyre; Renato C Monteiro; Ivan C Moura; Olivier Hermine
Journal:  J Exp Med       Date:  2010-04-05       Impact factor: 14.307

9.  Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine.

Authors:  William H Chappell; Stephen L Abrams; Richard A Franklin; Michelle M LaHair; Giuseppe Montalto; Melchiorre Cervello; Alberto M Martelli; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Jerry Polesel; Renato Talamini; Michele Milella; Agostino Tafuri; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

10.  Chemical substructures that enrich for biological activity.

Authors:  Justin Klekota; Frederick P Roth
Journal:  Bioinformatics       Date:  2008-09-10       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.